These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. An Automatically Adaptive Digital Health Intervention to Decrease Opioid-Related Risk While Conserving Counselor Time: Quantitative Analysis of Treatment Decisions Based on Artificial Intelligence and Patient-Reported Risk Measures. Piette JD; Thomas L; Newman S; Marinec N; Krauss J; Chen J; Wu Z; Bohnert ASB J Med Internet Res; 2023 Jul; 25():e44165. PubMed ID: 37432726 [TBL] [Abstract][Full Text] [Related]
85. Attitudes and beliefs about Vermont's 2021 buprenorphine decriminalization law among residents who use illicit opioids. Feder KA; Harris SJ; Byrne L; Miller SM; Sodder S; Berman V; Livingston A; Edwards J; Hartman S; Sugarman OK; Shah H; Xu J; Raikes J; Gattine S; Saloner B Drug Alcohol Depend; 2023 Sep; 250():110879. PubMed ID: 37473698 [TBL] [Abstract][Full Text] [Related]
86. Feasibility of using interactive voice response to monitor daily drinking, moods, and relationship processes on a daily basis in alcoholic couples. Cranford JA; Tennen H; Zucker RA Alcohol Clin Exp Res; 2010 Mar; 34(3):499-508. PubMed ID: 20028351 [TBL] [Abstract][Full Text] [Related]
87. Feasibility of an interactive voice response tool for adolescent assault victims. Blackstone MM; Wiebe DJ; Mollen CJ; Kalra A; Fein JA Acad Emerg Med; 2009 Oct; 16(10):956-62. PubMed ID: 19799571 [TBL] [Abstract][Full Text] [Related]
88. The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance. Moore BA; Fazzino T; Barry DT; Fiellin DA; Cutter CJ; Schottenfeld RS; Ball SA J Subst Abuse Treat; 2013 Jul; 45(1):63-9. PubMed ID: 23375114 [TBL] [Abstract][Full Text] [Related]
89. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. Alford DP; LaBelle CT; Richardson JM; O'Connell JJ; Hohl CA; Cheng DM; Samet JH J Gen Intern Med; 2007 Feb; 22(2):171-6. PubMed ID: 17356982 [TBL] [Abstract][Full Text] [Related]
90. Using interactive voice response to enhance brief alcohol intervention in primary care settings. Helzer JE; Rose GL; Badger GJ; Searles JS; Thomas CS; Lindberg SA; Guth S J Stud Alcohol Drugs; 2008 Mar; 69(2):251-8. PubMed ID: 18299766 [TBL] [Abstract][Full Text] [Related]
91. Feasibility and reliability of interactive voice response assessment of HIV medication adherence: research and clinical implications. Hettema JE; Hosseinbor S; Ingersoll KS HIV Clin Trials; 2012; 13(5):271-7. PubMed ID: 23134627 [TBL] [Abstract][Full Text] [Related]
92. A pilot study of mindful body awareness training as an adjunct to office-based medication treatment of opioid use disorder. Price CJ; Merrill JO; McCarty RL; Pike KC; Tsui JI J Subst Abuse Treat; 2020 Jan; 108():123-128. PubMed ID: 31174929 [TBL] [Abstract][Full Text] [Related]
93. "The Doctor Says You Cannot Have [Buprenorphine]" Autonomy and Use of Prescribed or Non-Prescribed Buprenorphine. Hayes BT; Jakubowski A; Fitzsimmons C; Garcia B; Ramirez F; Fox AD Subst Use Misuse; 2021; 56(8):1137-1143. PubMed ID: 33939937 [TBL] [Abstract][Full Text] [Related]
94. Association between interactive voice response adherence and subject retention in a randomized controlled trial. Gatehouse CS; Tennen HA; Feinn RS; Abu-Hasaballah KS; Lalla RV Contemp Clin Trials; 2012 Jul; 33(4):589-92. PubMed ID: 22484338 [TBL] [Abstract][Full Text] [Related]
95. Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids. Daniulaityte R; Falck R; Carlson RG Drug Alcohol Depend; 2012 May; 122(3):201-7. PubMed ID: 22036303 [TBL] [Abstract][Full Text] [Related]
96. Comparison of drinking patterns measured by daily reports and timeline follow back. Searles JS; Helzer JE; Walter DE Psychol Addict Behav; 2000 Sep; 14(3):277-86. PubMed ID: 10998953 [TBL] [Abstract][Full Text] [Related]
97. Urinalysis based assessment of compliance and drug use patterns in patients prescribed tramadol: A cross-sectional study from a tertiary care centre. Jain R; Sarkar S; Saifi N; Ghosh S Asian J Psychiatr; 2022 May; 71():103080. PubMed ID: 35305452 [TBL] [Abstract][Full Text] [Related]
98. Satisfaction with group-based appointments among patients with opioid use disorder in an urban buprenorphine clinic. Akyar S; Nyaku A; Lao K; Ruthberg S; Zerbo EA Subst Abus; 2022; 43(1):913-916. PubMed ID: 35226591 [No Abstract] [Full Text] [Related]
99. Effects of live-online, group mindfulness training on opioid use and anxiety during buprenorphine treatment: A comparative effectiveness RCT. Rosansky JA; Howard L; Goodman H; Okst K; Fatkin T; Fredericksen AK; Sokol R; Gardiner P; Parry G; Cook BL; Weiss RD; Schuman-Olivier ZD Contemp Clin Trials; 2024 Feb; 137():107417. PubMed ID: 38135210 [TBL] [Abstract][Full Text] [Related]
100. Automated screening for at-risk drinking in a primary care office using interactive voice response. Rose GL; Skelly JM; Badger GJ; Maclean CD; Malgeri MP; Helzer JE J Stud Alcohol Drugs; 2010 Sep; 71(5):734-8. PubMed ID: 20731979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]